Sang-Joon Lee
Chief Executive Officer bij HYUNDAI PHARMACEUTICAL CO., LTD.
Vermogen: 4 M $ op 31-03-2024
Profiel
Sang-Joon Lee is currently the President, CEO, Director, and Head of R&D at Hyundai Pharmaceutical Co., Ltd.
He is also the Chief Executive Officer at Bioinnotis.
Mr. Lee holds an MBA from the University of San Diego.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 28-02-2023 | 1 351 612 ( 4.22% ) | 4 M $ | 31-03-2024 |
Actieve functies van Sang-Joon Lee
| Bedrijven | Functie | Begin |
|---|---|---|
| HYUNDAI PHARMACEUTICAL CO., LTD. | Chief Executive Officer | 28-02-2003 |
Bioinnotis
 Bioinnotis Miscellaneous Commercial ServicesCommercial Services Bioinnotis is a research institute that focuses on developing innovative pharmaceutical drugs and technologies. The private company is based in Seoul, South Korea. The CEO of the South Korean company is Sang-Joon Lee. | Chief Executive Officer | - |
Opleiding van Sang-Joon Lee
| University of San Diego | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HYUNDAI PHARMACEUTICAL CO., LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Bioinnotis
Bioinnotis Miscellaneous Commercial ServicesCommercial Services Bioinnotis is a research institute that focuses on developing innovative pharmaceutical drugs and technologies. The private company is based in Seoul, South Korea. The CEO of the South Korean company is Sang-Joon Lee. | Commercial Services |
